Normal-pressure hydrocephalus

Contributors
Article section 16 of 16.  Previous  

By Peter Hedera MD and Robert P Friedland MD

Peter Hedera MD PhD, author. Dr. Hedera of Vanderbilt University has no relevant financial relationships to disclose.

Robert P Friedland MD, author. Dr. Friedland of the University of Louisville School of Medicine has no relevant financial relationships to disclose.

Martin Farlow MD, editor. Dr. Farlow of Indiana University School of Medicine received grant or research support from Eli Lilly, Novartis, Sanofi Aventis, Roche, Genentech, Eisai, Biogen, Accera and Navidea; speakers bureau fees from Eisai, Pfizer, Forest and Novartis; consulting or advisory board fees from Accera, Alltech, Avanir, Eisai, Med Res, Inc., Grifols, Helicon, INC Research, Medavante, Medivation, Inc., Merck, Novartis, Pfizer, Prana Biotech, QR Pharma, Roche, Sanofi Aventis, Schering-Plough, Toyama Pharm, Lilly, Shire Pharmaceuticals, UCB Pharma; and patent licensing fees from Elan.

In This Article

Introduction
Historical note and nomenclature
Clinical manifestations
Clinical vignette
Etiology
Pathogenesis and pathophysiology
Epidemiology
Prevention
Differential diagnosis
Diagnostic workup
Prognosis and complications
Management
Pregnancy
Anesthesia
References cited
Contributors